Skip to main navigation Skip to search Skip to main content

Variation in the CTLA4 3′UTR has phenotypic consequences for autoreactive T cells and associates with genetic risk for type 1 diabetes

  • V. M. de Jong*
  • , A. Zaldumbide
  • , A. R. van der Slik
  • , S. Laban
  • , B. P C Koeleman
  • , B. O. Roep
  • *Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

1 Downloads (Pure)

Abstract

Cytotoxic T-lymphocyte-associated protein 4 (CTLA4) is a protein receptor that downregulates the immune system. CTLA4 gene variants associate with various autoimmune diseases, including type 1 diabetes. Fine mapping of the genetic risk has shown that the genomic region near CTLA4 marked by the single-nucleotide polymorphism (SNP) CT60A/G (rs3087243) acts as a susceptibility factor. Yet, the functional basis for the increased susceptibility conferred by rs3087243 remains unclear. We demonstrate that the length of the dinucleotide (AT)n repeat within the CTLA4 3’ untranslated region (3′UTR) strongly associates with the risk of SNP CT60A/G (P<6.5 × 10-72). Genomic (AT)n repeat length inversely correlated with CTLA4 messenger RNA (mRNA) and protein levels in islet autoreactive T-cell lines. Transfer of a long (AT)n element into T cells lead to a reduction of mRNA compared to a short (AT)n element. Thus, this study provides evidence for a role of the CTLA4 3′UTR (AT)n repeat in the increased genetic risk for islet autoimmunity associated with the CTLA4 locus.

Original languageEnglish
Pages (from-to)75-78
JournalGenes and Immunity
Volume17
DOIs
Publication statusPublished - 2016

Fingerprint

Dive into the research topics of 'Variation in the CTLA4 3′UTR has phenotypic consequences for autoreactive T cells and associates with genetic risk for type 1 diabetes'. Together they form a unique fingerprint.

Cite this